23rd Annual Psychopharmacology Update 2024 covers topics such as:
Evidence-based strategies for treating youth at familial risk for developing bipolar disorder
The pros and cons of various pharmacotherapeutic options in depression, schizophrenia, bipolar disorders, ADHD and child and adolescent psychiatric disorders
Evidence base involving the short- and long-term efficacy versus safety risks of antidepressants in patients with bipolar depression
Relative outcomes after augmentation versus switching strategies in treatment-resistant depression
Data relevant to the therapeutic profile of lithium vs. anticonvulsants in the treatment of bipolar disorder
Differentiate bipolar disorder from ADHD even when they co-exist
23rd Annual Psychopharmacology Update 2024 brings together senior attendees with job titles such as:
General psychiatrists
Child and adolescent psychiatrists
Nurse practitioners
Geriatric psychiatrists
Nurses
Physician assistants
Social workers
Psychologists
Other mental health professionals
Venue
Hyatt Regency Cincinnati ,
151 West Fifth Street, Cincinnati, Ohio, United States
We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept", you consent to our use of cookies. You can manage your preferences or learn more by clicking "Customize" or visiting our Cookies Policy page.
